Childhood-onset PsA in Down syndrome with psoriasis susceptibility variant CARD14 rs11652075

Rheumatology (Oxford). 2015 Jan;54(1):197-9. doi: 10.1093/rheumatology/keu419. Epub 2014 Oct 22.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age of Onset
  • Antibodies, Monoclonal / therapeutic use
  • Arthritis, Psoriatic / diagnosis
  • Arthritis, Psoriatic / drug therapy
  • Arthritis, Psoriatic / genetics*
  • CARD Signaling Adaptor Proteins / genetics*
  • Down Syndrome / genetics*
  • Genetic Predisposition to Disease / genetics*
  • Genetic Variation / genetics*
  • Guanylate Cyclase / genetics*
  • Homozygote
  • Humans
  • Infliximab
  • Male
  • Membrane Proteins / genetics*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • CARD Signaling Adaptor Proteins
  • Membrane Proteins
  • Infliximab
  • CARD14 protein, human
  • Guanylate Cyclase